Carolyn McAuliffe active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Public Communications Contact | 2021-09-12 | - |
Career history of Carolyn McAuliffe
Former positions of Carolyn McAuliffe
| Companies | Position | Start | End |
|---|---|---|---|
| MASIMO CORPORATION | Public Communications Contact | - | - |
Statistics
International
| United States | 3 |
Operational
| Public Communications Contact | 2 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MASIMO CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Carolyn McAuliffe
- Experience
